Skip To Main Content
Rudra Narayan Swain on Muck Rack

Rudra Narayan Swain

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rudra Narayan

Contact Rudra Narayan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Fixed-duration cytarabine consolidation improves relapse-free survival over indefinite AZA–VEN in younger AML

|
By Arihant Jain, Charanpreet Singh, Aditya Jandial, Alka Khadwal, Shano Naseem, Pankaj Malhotra, Gaurav Prakash, Rudra Narayan Swain, Sarthak Wadhera, Man Updesh Sachdeva
| Nature Verified
To the Editor, The treatment of newly diagnosed Acute Myeloid Leukaemia (ND-AML) requires a personalised approach based on age, comorbidities, and functional status of a patient. The azacitidine–venetoclax (Aza-Ven) regimen, though initially approved for elderly or unfit patients, is now increasingly used in younger adults (<65 years) who are not suitable for intensive chemotherapy.
Open in Who Shared Issue with article?
See all 1 articles